Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.67 - $4.4 $57,949 - $152,680
34,700 New
34,700 $137,000
Q1 2024

May 15, 2024

BUY
$1.23 - $1.86 $1,968 - $2,976
1,600 Added 15.84%
11,700 $19,000
Q4 2023

Feb 14, 2024

BUY
$1.58 - $2.44 $15,958 - $24,644
10,100 New
10,100 $19,000

Others Institutions Holding RMTI

About ROCKWELL MEDICAL, INC.


  • Ticker RMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,675,200
  • Market Cap $22.8M
  • Description
  • Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...
More about RMTI
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.